Illumina-Grail saga to resume imminently with EU gun-jumping penalty and unwinding measures
US life-sciences giant Illumina can expect its formal fining decision from the European Commission within weeks on charges of jumping the gun on its merger with cancer-detection specialist Grail, MLex has...To view the full article, register now.
Already a subscriber? Click here to view full article